ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed
Nicholas D. Nguyen
Matched on ORCID iD 0000-0002-3481-0672; OpenAlex author ID A5078118339. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 31
2019: 1 paper · 2020: 2 papers · 2021: 3 papers · 2022: 1 paper
Papers 7
- Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment. Co-author DOI 10.1053/j.gastro.2022.02.024↗
- Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer. Co-author DOI 10.1016/j.adro.2020.11.006↗
- Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era. Co-author DOI 10.1016/j.adro.2021.100763↗
- Comparative Untargeted Metabolomic Profiling of Induced Mitochondrial Fusion in Pancreatic Cancer. Co-author DOI 10.3390/metabo11090627↗
- Radiation therapy for patients with locally advanced pancreatic cancer: Evolving techniques and treatment strategies. Co-author DOI 10.1016/j.currproblcancer.2020.100607↗
- Patient-Reported Outcome Measures in Pancreatic Cancer Receiving Radiotherapy. Co-author DOI 10.3390/cancers12092487↗
- Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. First author DOI 10.1172/jci.insight.126915↗
Closest collaborators
The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Cullen M. Taniguchi · 7 shared papers, 2019–2022 · strength 0.78
- Paper Comparative Untargeted Metabolomic Profiling of Induced Mitochondrial Fusion in Pancreatic Cancer. DOI 10.3390/metabo11090627↗
- Paper Radiation therapy for patients with locally advanced pancreatic cancer: Evolving techniques and treatment strategies. DOI 10.1016/j.currproblcancer.2020.100607↗
- Paper Patient-Reported Outcome Measures in Pancreatic Cancer Receiving Radiotherapy. DOI 10.3390/cancers12092487↗
- Daniel Lin · 6 shared papers, 2019–2022 · strength 0.65
- Paper Radiation therapy for patients with locally advanced pancreatic cancer: Evolving techniques and treatment strategies. DOI 10.1016/j.currproblcancer.2020.100607↗
- Paper Patient-Reported Outcome Measures in Pancreatic Cancer Receiving Radiotherapy. DOI 10.3390/cancers12092487↗
- Paper Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment. DOI 10.1053/j.gastro.2022.02.024↗
- Joseph Abi Jaoude · 5 shared papers, 2020–2021 · strength 0.59
- Paper Comparative Untargeted Metabolomic Profiling of Induced Mitochondrial Fusion in Pancreatic Cancer. DOI 10.3390/metabo11090627↗
- Paper Radiation therapy for patients with locally advanced pancreatic cancer: Evolving techniques and treatment strategies. DOI 10.1016/j.currproblcancer.2020.100607↗
- Paper Patient-Reported Outcome Measures in Pancreatic Cancer Receiving Radiotherapy. DOI 10.3390/cancers12092487↗
- Ramez Kouzy · 4 shared papers, 2020–2021 · strength 0.46
- Paper Radiation therapy for patients with locally advanced pancreatic cancer: Evolving techniques and treatment strategies. DOI 10.1016/j.currproblcancer.2020.100607↗
- Paper Patient-Reported Outcome Measures in Pancreatic Cancer Receiving Radiotherapy. DOI 10.3390/cancers12092487↗
- Paper Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era. DOI 10.1016/j.adro.2021.100763↗
- Ethan Bernard Ludmir · 3 shared papers, 2020–2021 · strength 0.35
- Paper Radiation therapy for patients with locally advanced pancreatic cancer: Evolving techniques and treatment strategies. DOI 10.1016/j.currproblcancer.2020.100607↗
- Paper Patient-Reported Outcome Measures in Pancreatic Cancer Receiving Radiotherapy. DOI 10.3390/cancers12092487↗
- Paper Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era. DOI 10.1016/j.adro.2021.100763↗
- Meifang Yu · 3 shared papers, 2019–2022 · strength 0.33
- Paper Comparative Untargeted Metabolomic Profiling of Induced Mitochondrial Fusion in Pancreatic Cancer. DOI 10.3390/metabo11090627↗
- Paper Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment. DOI 10.1053/j.gastro.2022.02.024↗
- Paper Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. DOI 10.1172/jci.insight.126915↗
- Albert C. Koong · 3 shared papers, 2019–2021 · strength 0.28
- Paper Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era. DOI 10.1016/j.adro.2021.100763↗
- Paper Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pa… DOI 10.1016/j.adro.2020.11.006↗
- Paper Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. DOI 10.1172/jci.insight.126915↗
- Joseph M. Herman · 3 shared papers, 2019–2021 · strength 0.28
- Paper Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era. DOI 10.1016/j.adro.2021.100763↗
- Paper Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pa… DOI 10.1016/j.adro.2020.11.006↗
- Paper Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. DOI 10.1172/jci.insight.126915↗
- Eugene Jon Koay · 3 shared papers, 2019–2021 · strength 0.28
- Paper Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era. DOI 10.1016/j.adro.2021.100763↗
- Paper Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pa… DOI 10.1016/j.adro.2020.11.006↗
- Paper Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. DOI 10.1172/jci.insight.126915↗
- Carolina J. García García · 2 shared papers, 2021–2022 · strength 0.22
- Tara N. Fujimoto · 2 shared papers, 2019–2022 · strength 0.19
- Anirban Maitra · 2 shared papers, 2019–2022 · strength 0.19
- Abagail M. Delahoussaye · 1 shared paper, 2022 · strength 0.12
- Emily G. Caggiano · 1 shared paper, 2022 · strength 0.12
- Natividad Roberto Fuentes · 1 shared paper, 2022 · strength 0.12
- Maria E. Monberg · 1 shared paper, 2022 · strength 0.12
- Jaewon James Lee · 1 shared paper, 2022 · strength 0.12
- Jun Zhao · 1 shared paper, 2022 · strength 0.12
- Vincent Bernard · 1 shared paper, 2022 · strength 0.12
- Dieter Saur · 1 shared paper, 2022 · strength 0.12
- Matthew H. G. Katz · 1 shared paper, 2021 · strength 0.10
- Laura R. Prakash · 1 shared paper, 2021 · strength 0.10
- Irina Mihaela Cazacu · 1 shared paper, 2021 · strength 0.10
- Grace L. Smith · 1 shared paper, 2021 · strength 0.10
- Shalini Moningi · 1 shared paper, 2021 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.